Somewhere in nearly every major pharma and medtech organization, there is a slide deck showing dozens of active AI initiatives—and a CFO asking why so few are showing up in the financials. That question is becoming harder to avoid. Our survey of 133 life sciences executives, run in partnership with the Mayfield Fund, found that only 20% of organizations are consistently deploying AI at scale and achieving meaningful, measurable value. The tools have not failed the other 80%.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Lori
Contact Lori, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack